CIK: 0001792126 · Show all filings
Period: Q3 2020 (← Previous) (Next →)
Filing Date: Nov 17, 2020
Total Value ($000): $781,397 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| ALXO | ALX ONCOLOGY HLDGS INC | 3,136,981 | $118,390 | 15.2% | $39.31 | 0.0% | COM | 00166B105 |
| KROS | KEROS THERAPEUTICS INC | 1,600,000 | $61,712 | 7.9% | $37.45 | +5.9% | COM | 492327101 |
| NKTX | NKARTA INC | 2,047,178 | $61,538 | 7.9% | $29.47 | 0.0% | COM | 65487U108 |
| — | FORMA THERAPEUTICS HLDGS INC | 1,173,188 | $58,472 | 7.5% | $46.49 | — | SHS | 34633R104 |
| — | GLOBAL BLOOD THERAPEUTICS IN | 850,000 | $46,869 | 6.0% | $54.50 | — | COM | 37890U108 |
| TGTX | TG THERAPEUTICS INC | 1,750,000 | $46,830 | 6.0% | $19.16 | +20.1% | COM | 88322Q108 |
| SRPT | SAREPTA THERAPEUTICS INC | 275,000 | $38,618 | 4.9% | $151.97 | 0.0% | COM | 803607100 |
| DYN | DYNE THERAPEUTICS INC | 1,604,392 | $32,393 | 4.1% | $21.96 | 0.0% | COM | 26818M108 |
| — | REPARE THERAPEUTICS INC | 976,894 | $30,059 | 3.8% | $30.54 | — | COM | 760273102 |
| — | BIOXCEL THERAPEUTICS INC | 550,000 | $23,848 | 3.1% | $48.62 | — | COM | 09075P105 |
| RNAM | AVIDITY BIOSCIENCES INC | 721,454 | $20,309 | 2.6% | $28.83 | +0.2% | COM | 05370A108 |
| — | ATHIRA PHARMA INC | 1,020,812 | $18,844 | 2.4% | $18.46 | — | COM | 04746L104 |
| CLDX | CELLDEX THERAPEUTICS INC NEW | 1,200,000 | $17,796 | 2.3% | $4.43 | +164.3% | COM NEW | 15117B202 |
| CMPS | COMPASS PATHWAYS PLC | 500,000 | $17,450 | 2.2% | $34.90 | — | SPONSORED ADS | 20451W101 |
| CYTK | CYTOKINETICS INC | 750,000 | $16,238 | 2.1% | $17.31 | +35.2% | COM NEW | 23282W605 |
| — | SAGE THERAPEUTICS INC | 250,000 | $15,280 | 2.0% | $61.12 | — | COM | 78667J108 |
| — | CALLIDITAS THERAPEUTICS AB | 550,000 | $13,200 | 1.7% | $23.62 | — | SPONSERED ADS | 13124Q106 |
| — | BRISTOL-MYERS SQUIBB CO | 5,500,000 | $12,375 | 1.6% | $3.09 | — | RIGHT 99/99/9999 | 110122157 |
| KYMR | KYMERA THERAPEUTICS INC | 300,920 | $9,723 | 1.2% | $30.53 | 0.0% | COM | 501575104 |
| NRIX | NURIX THERAPEUTICS INC | 275,000 | $9,600 | 1.2% | $25.20 | 0.0% | COM | 67080M103 |
| HRMY | HARMONY BIOSCIENCES HLDGS IN | 275,000 | $9,323 | 1.2% | $36.46 | 0.0% | COM | 413197104 |
| — | ITEOS THERAPEUTICS INC | 300,000 | $7,401 | 0.9% | $24.67 | — | COM | 46565G104 |
| — | THERAPEUTICS ACQUISITION COR | 500,000 | $7,190 | 0.9% | $14.38 | — | COM CL A | 88339T103 |
| — | AKOUOS INC | 310,000 | $7,090 | 0.9% | $22.50 | — | COM | 00973J101 |
| — | UNUM THERAPEUTICS INC | 2,700,000 | $6,318 | 0.8% | $2.34 | — | COM | 903214104 |
| — | INHIBRX INC | 311,578 | $5,608 | 0.7% | $18.00 | — | COM | 45720L107 |
| — | LIFESCI ACQUISITION CORP | 400,000 | $5,440 | 0.7% | $10.00 | — | UNIT 03/31/2025 | 53228P208 |
| PMVP | PMV PHARMACEUTICALS INC | 150,000 | $5,325 | 0.7% | $36.80 | 0.0% | COM | 69353Y103 |
| — | PANDION THERAPEUTICS INC | 450,000 | $5,157 | 0.7% | $11.46 | — | COM | 698340106 |
| LRMR | LARIMAR THERAPEUTICS INC | 330,000 | $5,006 | 0.6% | $12.49 | +1.4% | COM | 517125100 |
| — | OUTSET MED INC | 100,000 | $5,000 | 0.6% | $50.00 | — | COM | 690145107 |
| ANNX | ANNEXON INC | 159,622 | $4,825 | 0.6% | $23.46 | 0.0% | COM | 03589W102 |
| — | PASSAGE BIO INC | 344,438 | $4,516 | 0.6% | $14.85 | — | COM | 702712100 |
| RLAY | RELAY THERAPEUTICS INC | 100,000 | $4,259 | 0.5% | $38.13 | 0.0% | COM | 75943R102 |
| KALV | KALVISTA PHARMACEUTICALS INC | 300,000 | $3,777 | 0.5% | $10.63 | +17.6% | COM | 483497103 |
| BDTX | BLACK DIAMOND THERAPEUTICS I | 123,465 | $3,732 | 0.5% | $30.22 | +0.7% | COM | 09203E105 |
| — | INARI MED INC | 50,000 | $3,451 | 0.4% | $69.02 | — | COM | 45332Y109 |
| — | HEALTH SCIENCES ACQ CORP 2 | 300,000 | $3,300 | 0.4% | $11.00 | — | ORD SHS | G4411D109 |
| PLRX | PLIANT THERAPEUTICS INC | 136,715 | $3,097 | 0.4% | $26.54 | -5.8% | COM | 729139105 |
| — | PANACEA ACQUISITION CORP | 200,000 | $2,400 | 0.3% | $12.00 | — | UNIT 99/99/9999 | 698102209 |
| AFIB | ACUTUS MED INC | 75,000 | $2,235 | 0.3% | $30.36 | 0.0% | COM | 005111109 |
| — | CHARDAN HEALTHCR ACQSTN 2 CO | 200,000 | $2,110 | 0.3% | $10.50 | — | UNIT 99/99/9999 | 15957T206 |
| — | BCTG ACQUISITION CORP | 200,000 | $2,072 | 0.3% | $10.36 | — | COM | 05492W103 |
| — | FS DEV CORP | 100,000 | $1,120 | 0.1% | $11.20 | — | COM CL A | 303020101 |
| — | ARYA SCIENCES ACQUISTION CO | 100,000 | $1,100 | 0.1% | $11.60 | — | UNIT 06/09/2027 | G31655114 |
| — | RAPT THERAPEUTICS INC | 31,100 | $1,001 | 0.1% | $29.02 | — | COM | 75382E109 |